Table 2. Subsequent Memory Scores and Changes (Δ=1 Year−Baseline): Mean (SD).
Memantine (N=21) |
Placebo (N=20) |
p* | |||||
---|---|---|---|---|---|---|---|
Baseline | 1 Year | Δ | Baseline | 1 Year | Δ | ||
FR—both | 13.2 (10.4) | 14.7 (13) | 1.48 | 14.1 (9.7) | 16.6 (11) | 2.45 | 0.76 |
FR—congruous | 10.7 (8.1) | 11.7 (9.8) | 1.05 | 12.3 (8.3) | 13.9 (9.5) | 1.60 | 0.86 |
CR—both | 15.7 (4.6) | 18.8 (4.0) | 3.13 | 17.8 (3.7) | 18.5 (4.9) | 0.70 | 0.037* |
CR—congruous | 15.2 (4.0) | 18.1 (3.1) | 2.95 | 16.9 (3.4) | 17.5 (4.2) | 0.60 | 0.027* |
MC—both | 28.3 (9.6) | 32.2 (6.5) | 3.90 | 27.6 (8.8) | 29.0 (8.1) | 1.45 | 0.21 |
MC—congruous | 18.5 (5.5) | 20.1 (2.0) | 1.62 | 18.9 (4.0) | 19.2 (3.2) | 0.30 | 0.29 |
Abbreviations: CR, cued-recall, FR, free recall, MC, multiple-choice. p-Values are for the visit × treatment interactions from ANCOVAs controlling for gender). *p<0.05.